Spiro Rombotis serves as Executive at Cyclacel Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Spiro Rombotis has executed 9 insider transactions totaling $14.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 15, 2006 involved purchasing 1,300 shares valued at $7.2K.
Spiro Rombotis currently holds 356,448 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Spiro Rombotis has been a net buyer of CYCC stock. They have purchased $14.3K and sold $0 worth of shares.
Spiro Rombotis's most recent insider trade was on Sep 15, 2006, when they purchased 1,300 shares at $5.56 per share.
Get notified when new Form 4 filings are submitted
| $6.10 |
| Discretionary |
| Sep 12, 2006 | CYCC | $595 | Purchase | 100 | $5.95 | Discretionary |
| Sep 11, 2006 | CYCC | $580 | Purchase | 100 | $5.80 | Discretionary |
| Sep 8, 2006 | CYCC | $1.7K | Purchase | 300 | $5.69 | Discretionary |
| Sep 7, 2006 | CYCC | $1.3K | Purchase | 300 | $4.43 | Discretionary |
| Sep 6, 2006 | CYCC | $1.5K | Purchase | 300 | $4.90 | Discretionary |
| Apr 17, 2006 | CYCC | $774 | Purchase | 100 | $7.74 | Discretionary |
| Mar 27, 2006 | CYCC | $0 | Other | 353,848 | $N/A | Discretionary |